Brain Stimulation (May 2023)

Focused ultrasound neuromodulation of the spleen activates an anti-inflammatory response in humans

  • Stavros Zanos,
  • Despoina Ntiloudi,
  • John Pellerito,
  • Richard Ramdeo,
  • John Graf,
  • Kirk Wallace,
  • Victoria Cotero,
  • Jeff Ashe,
  • Jessica Moon,
  • Meghan Addorisio,
  • David Shoudy,
  • Thomas R. Coleman,
  • Michael Brines,
  • Chris Puleo,
  • Kevin J. Tracey,
  • Sangeeta S. Chavan

Journal volume & issue
Vol. 16, no. 3
pp. 703 – 711

Abstract

Read online

Focused ultrasound stimulation (FUS) activates mechanosensitive ion channels and is emerging as a method of noninvasive neuromodulation. In preclinical studies, FUS of the spleen (sFUS) activates an anti-inflammatory neural pathway which suppresses acute and chronic inflammation. However, the relevance of sFUS for regulating inflammatory responses in humans is unknown. Here, we used a modified diagnostic ultrasound imaging system to target the spleen of healthy human subjects with 3 min of continuously swept or stationary focused pulsed ultrasound, delivered at three different energy levels within allowable safety exposure limits. Potential anti-inflammatory effects of sFUS were assessed by measuring sFUS-elicited changes in endotoxin-induced tumor necrosis factor (TNF) production in whole blood samples from insonified subjects. We found that stimulation with either continuously swept or focused pulsed ultrasound has an anti-inflammatory effect: sFUS lowers TNF production for >2 h, with TNF returning to baseline by 24 h following sFUS. This response is independent of anatomical target (i.e., spleen hilum or parenchyma) or ultrasound energy level. No clinical, biochemical, or hematological parameters are adversely impacted. This is the first demonstration that sFUS suppresses the normal inflammatory response in humans, with potential implications for noninvasive bioelectronic therapy of inflammatory disorders.

Keywords